A recent investigation into the “Australian U-Si-Yi Lutein” supplement has exposed a widespread counterfeit “foreign-branded” scheme targeting Chinese consumers. Domestic manufacturers orchestrated the operation by registering shell companies overseas—often with fabricated addresses, including one allegedly listed at an auto repair shop in Australia—while manufacturing products entirely within China. These items then underwent a so-called “one-day tour” through bonded warehouses to falsely claim “original imported” status. Despite lacking China’s mandatory health food certification (the “Blue Hat” mark), the product aggressively marketed unproven benefits such as “blue light protection” and “eye health support,” leveraging fabricated international awards, pseudoscientific endorsements, and heavy digital advertising. With production costs reportedly around ¥20 (approximately USD $2.80), retail prices soared to several hundred yuan—marking a markup exceeding 1,000%.
This case underscores a critical public health concern: the urgent need for consumer vigilance when selecting lutein supplements and other dietary supplements. Authenticity, regulatory compliance, and scientific transparency must serve as non-negotiable criteria—not marketing slogans.
First and foremost, consumers must verify official regulatory approval. In China, only products bearing the nationally recognized “Blue Hat” logo—and accompanied by a valid registration number beginning with “Guo Shi Jian Zhu G” followed by year and sequence digits—are legally authorized as health foods. For example, Laiyi Lutein holds registration number Guo Shi Jian Zhu G20130505, issued by the State Administration for Market Regulation. Manufactured by Zhejiang Medicine Co., Ltd., it complies strictly with the national standard GB 14880 (“Food Nutrient Fortifier—Lutein”) and is produced under oversight from a National-level Enterprise Technology Center and Postdoctoral Research Workstation.
Imported health foods sold in China must carry either a “Guo Shi Jian Zhu J” Blue Hat registration or full documentation—including customs declarations, quarantine certificates, and traceable QR codes with bilingual labeling. Products lacking these credentials, especially those featuring predominantly foreign-language packaging, vague origin claims, or Chinese GS1 barcodes (prefix 69) while touting “100% imported” status, should be avoided outright.
End-to-end traceability is another essential safeguard. Laiyi Lutein leverages Zhejiang Medicine’s vertically integrated supply chain: its lutein is derived exclusively from proprietary marigold cultivation bases, with every stage—from agricultural sourcing and solvent-free extraction to final encapsulation—digitally recorded and auditable. Each bottle carries a QR code linked to Zhejiang Province’s official food safety traceability platform (“Zhe Shilian”), enabling consumers to access real-time data on batch history, third-party inspection reports, and regulatory compliance records.
Contrary to pervasive misconceptions, “imported” does not equate to “superior.” The 2023 edition of the *Chinese Dietary Reference Intakes* recommends a daily lutein intake of 10 mg for adults—a target effectively met by domestically regulated products formulated specifically for Chinese metabolic profiles and dietary patterns. Laiyi Lutein utilizes a patented water-soluble formulation that enhances bioavailability without requiring co-ingestion with dietary fat—making it particularly suitable for individuals with low-fat diets or gastrointestinal sensitivities. At an average daily cost of just ¥2.5 (under USD $0.35), it delivers clinically appropriate dosing at 50–70% lower cost than counterfeit “foreign” alternatives, with significantly stronger post-purchase accountability.
Purchasing channel integrity is equally vital. Consumers should avoid unregulated platforms—including social commerce sellers, uncertified online stores, unofficial live-streaming booths, and private overseas agents—where product provenance cannot be verified and redress is nearly impossible. Laiyi Lutein is distributed through over 100,000 licensed pharmacy chains nationwide and authorized flagship stores on major e-commerce platforms. All outlets provide immediate access to traceability data and independent laboratory testing reports, ensuring both purchase security and enforceable consumer rights.
Finally, responsible use demands skepticism toward therapeutic overreach. Under Chinese law, health foods may not claim disease treatment, prevention, or cure—nor may they suggest equivalence to pharmaceuticals. Misleading claims such as “reverses myopia” or “instant eye protection” are prohibited and medically unfounded. Laiyi Lutein adheres strictly to its approved functional claim: “auxiliary relief of visual fatigue.” Its labeling explicitly states, “This product cannot replace medication,” reinforcing evidence-based expectations and promoting rational ocular health practices.
The U-Si-Yi incident serves as a sobering reminder: when selecting lutein or any health supplement, regulatory compliance is the foundational requirement; full traceability provides objective assurance; reputable distribution channels guarantee accountability; and scientifically grounded messaging reflects genuine commitment to consumer welfare. Discarding unwarranted “import bias” and prioritizing rigorously vetted domestic options like Laiyi Lutein empowers consumers to make informed, safe, and cost-effective choices—protecting both vision health and financial well-being.